Cork tree bark extract, exercise each slow aggressive prostate cancer
January 27, 2020
Study results indicate that the tree bark extract and exercise work equally well, but use different pathways.
AJMC: Dr. Ruben Mesa outlines the quality of life impact of myelofibrosis
January 27, 2020
Ruben Mesa, MD, director of Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, discusses the impact myelofibrosis has on patients’ quality of life while at the American Society of Hematology conference.
Cure Today: Addressing the symptom burden of patients with MPN
January 24, 2020
Dr. Robyn Scherber,created an assessment form to help patients with myeloproliferative neoplasms explain their symptoms to their care team.
Targeted Oncology: Expert highlights benefits of Fedratinib in subgroup of patients with myelofibrosis
January 22, 2020
Dr. Ruben Mesa, director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, discussed the benefits of Fedratinib (Inrebic) for the treatment of adult patients with intermediate-2 or high-risk primary or secondary myelofibrosis. Read the full story
OncLive: Dr. Mesa on the efficacy of fedratinib in patients with myelofibrosis and low platelet counts
January 17, 2020
Ruben A. Mesa, MD, director, The Mays Cancer Center, the newly named center of UT Health San Antonio MD Anderson Cancer Center, discusses the efficacy of fedratinib in patients with myelofibrosis who have low platelet counts. Read the full story at OncLive
Dr. Dahia receives UT System award to expand her research on rare endocrine tumors
January 15, 2020
The $1 million UT System Faculty STARs award will be used to develop a center for the study, diagnosis and treatment planning of patients with endocrine tumors.
